Page last updated: 2024-08-25

rosiglitazone and Hyperglycemia, Postprandial

rosiglitazone has been researched along with Hyperglycemia, Postprandial in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	38 (51.35)	29.6817
2010's	34 (45.95)	24.3611
2020's	2 (2.70)	2.80

Authors

Authors	Studies
Burris, TP; Combs, DW; Demarest, KT; Rybczynski, PJ; Turchi, I; Xu, JZ; Yang, M; Zeck, RE	1
Berger, JP; Bergman, JP; Desai, RC; Doebber, TW; Gratale, DF; Han, W; Heck, JV; Leung, K; MacNaul, KL; Metzger, EJ; Moller, DE; Sahoo, SP	1
Henke, BR	1
Araki, K; Arita, T; Furukawa, A; Hayashi, S; Kuroha, M; Matsui, Y; Ohsumi, J; Satoh, S; Wakabayashi, K	1
Abdallah, AE; Eissa, IH; ElSohly, MA; Ibrahim, MK; Metwaly, AM; Radwan, MM	1
Huang, T; Song, J; Wei, X; Zhang, M; Zhao, J; Zhao, Y; Zhou, Y	1
Alawi, LF; Chodavarapu, H; El-Amouri, SS; Elased, KM; Emberesh, SE; Fadnavis, R; Owuor, BA	1
Adanichkin, N; Campbell, JM; Kurmis, R; Munn, Z	1
Yin, Q; Zhuang, Y	1
Rimbach, G; Schrader, E; Wein, S; Wolffram, S	1
Chodavarapu, H; Elased, KM; Grobe, N; Madhu, M; Salem, ES; Somineni, HK	1
Huang, HG; Lin, YH; Lou, M; Sun, JZ; Wen, SQ; Zhang, FH	1
Chang, Y; Hu, S; Li, Z; Wang, J; Wang, Y; Xue, C	1
Allen, SR; Cawyer, CR; Horvat, D; Jones, RO; Kuehl, TJ; Leonard, D; Uddin, MN; Zawieja, DC	1
Agarwal, S; Bilezikian, JP; Fitzpatrick, LA; Manavalan, JS; McMahon, DJ; Nino, A; Rubin, MR	1
Berggren-Söderlund, M; Feng, Y; Luo, G; Mu, Q; Nilsson-Ehle, P; Qin, L; Shi, Y; Xu, N; Zhang, J; Zhang, X; Zheng, L	1
Chen, Y; Han, H; Liu, B; Wang, J; Xu, F; Xue, M; Yuan, Q	1
Chen, M; Feng, T; Han, X; Li, N; Li, Y; Liu, C; Liu, P; Si, S; Wang, X; Xu, Y; Zhu, N	1
Beeram, MR; Kohl-Thomas, BM; Kuehl, TJ; Lin, S; Nguyen, T; Pantho, AF; Uddin, MN; Zawieja, DC	1
Cander, S; Ersoy, C; Guclu, M; Oz Gul, O; Ozkaya, G; Sarandol, E; Unal, O	1
Han, JS; Park, MH	1
Kavimani, S; Kesavanarayanan, KS; Prathiba, D; Priya, RJ; Selvakkumar, C	1
Cho, DH; Jo, I; Kim, SA; Park, JH; Park, JY; Seo, J; Song, KH	1
Chao, CY; Hsu, CC; Kuo, YH; Li, PY; Tang, FY; Yin, MC	1
Afroze, SH; Allen, S; Cawyer, C; Drever, N; Jones, R; Kuehl, T; Uddin, MN; Zawieja, DC	1
Cho, YM; Choi, HH; Chung, SS; Kim, JH; Lee, HK; Lee, KW; Park, HS; Park, KS	1
Gaikwad, AB; Pathan, AR; Ramarao, P; Viswanad, B	1
Chen, Y; Jimbu, YM; Lu, YL; Yang, H; Ye, TT; Zhao, JB	1
Choi, MS; Jeon, SM; Jung, UJ; Kang, YJ; Lee, MK; Song, H; Yeo, J	1
Lebovitz, HE	1
Scheen, AJ	2
Bosch, J; Dagenais, GR; Diaz, R; Gerstein, HC; Lonn, EM; Mohan, V; Sheridan, P; Smith, S; Yusuf, S	1
Gore, MO; McGuire, DK	1
McGill, JB	1
Jiang, JD; Kong, WJ; Pan, HN; Song, DQ; Wang, SK; Wang, YM; Wang, ZZ; Wei, J; Wu, JD; Xue, R; Zhang, H; Zhao, W; Zhou, ZX	1
Chajut, A; Cooper, A; Lee, S; Leizerman, I; Molero, JC; Walder, K	1
Bi, F; Liu, JN; Su, Y; Tang, Y; Zhang, J	1
Limor, R; Oron, Y; Rosenthal, T; Stern, N; Younis, F; Zangen, S	1
DeFronzo, RA; Glass, LC; Lewis, MS; Maggs, D; Qu, Y; Triplitt, C	1
Anand, S; Boyko, EJ; Gerstein, HC; Mohan, V; Shaw, JE; Sheridan, P; Yusuf, S	1
Bae, MH; Chae, YN; Choi, HH; Choi, SH; Hur, Y; Kim, E; Kim, JG; Kim, MK; Lim, JI; Moon, HS; Park, CS; Park, YH; Shin, CY; Son, MH	1
Fernandes, G; Halade, GV; Lindsey, ML; Williams, PJ	1
Rabøl, R	1
Elased, KM; Lucot, JB; Sharma, AN	1
Hart, CM; Lu, X; Sutliff, RL; Williams, CR	1
Feng, Y; Ruan, KF; Wang, LY; Wang, S; Wang, Y; Xu, DS	1
Chan, YC; Hong, LZ; Hung, SW; Tsai, CI; Tseng, CJ; Wang, JY; Wang, MF	1
Albertz, J; Duan, W; Guo, Z; Jin, J; Peng, Q; Ross, CA; Rudow, G; Troncoso, JC	1
Brewer, B; Gavrilova, O; Gonzalez, FJ; Haluzik, M; Lambert, G; Matsusue, K; Reitman, ML; Ward, JM; Yim, SH	1
Viberti, GC	1
Badiwala, MV; Fedak, PW; Li, RK; Li, SH; Mickle, DA; Verma, S; Wang, CH; Weisel, RD	1
Barringhaus, KG; Chen, M; Czarnik, AC; Hesselbacher, S; Ley, K; Nadler, J; Phillips, JW; Sanders, JM; Sarembock, IJ; Yang, Z	1
Evans, M; Rees, A; Roberts, AW; Thomas, A	1
Benelli, C; Duplus, E; Forest, C; Fouque, F; Reis, AF; Velho, G	1
Agrawal, A; Bennett, SM; Elasha, H; Heise, M; Jones, NP; Walker, M; Wilding, JP	1
Gavrilova, O; Haluzik, M; Kim, H; LeRoith, D; Pajvani, UB; Portas, J; Scherer, PE; Sun, H; Yakar, S	1
Chen, X; Cryan, E; Demarest, KT; Osborne, MC; Rybczynski, PJ; Tang, Y; Xu, J; Yang, M; Zeck, R; Zhou, L	1
Alonso, M; Vidal, A	1
Chow, WS; Hoo, RL; Kraegen, EW; Lam, KS; Sweeney, G; Tso, AW; Wang, Y; Wat, NM; Xu, A; Xu, JY; Zhang, J	1
Gaikwad, AB; Ramarao, P; Viswanad, B	1
Andres, J; Bähr, V; Bobbert, T; Diederich, S; Mai, K; Maser-Gluth, C; Möhlig, M; Pfeiffer, AF; Spranger, J	1
Goldberg, RB	1
Roussel, R	1
Abram, SR; Carter, C; Dearman, J; Hester, RL; Xiang, L	1
Kapoor, JR	1
Arch, JR; Buckingham, RE; Cai, XJ; Lister, CA; Pickavance, L; Wilding, J; Williams, G; Wilson, S	1
Stiefelhagen, P	1
Buckingham, RE; Lister, CA; Smith, SA; Toseland, CD	1
Boehm, M; Crombie, DL; Davies, PJ; Depre, C; Heyman, RA; Leibowitz, MD; Liu, S; Nagy, L; Singh Ahuja, H; Tontonoz, P	1
Akanuma, Y; Ezaki, O; Fukayama, M; Hori, W; Ide, T; Itai, A; Kadowaki, T; Kagechika, H; Kamon, J; Kato, S; Kimura, S; Komeda, K; Kubota, N; Miki, H; Motojima, K; Murakami, K; Nagai, R; Shudo, K; Terauchi, Y; Tobe, K; Tsuboyama-Kasaoka, N; Tsuchida, A; Waki, H; Yamauchi, N; Yamauchi, T	1
Lund, S; Pedersen, O; Vestergaard, H	1
Ardecky, RJ; Bean, JS; Bensch, WR; Bilakovics, JM; Broderick, CL; Brooks, DA; Brozinick, JT; Dana, SL; Etgen, GJ; Johnson, WT; Kauffman, RF; Liu, S; McCarthy, JR; Misener, EA; Montrose, CR; Ogilvie, KM; Oldham, BA; Paterniti, JR; Rito, CJ; Shuker, AJ; Tyhonas, JS	1

Reviews

8 review(s) available for rosiglitazone and Hyperglycemia, Postprandial

Article	Year
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes. Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17 Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors	2004
Intensive insulin therapy, insulin sensitisers and insulin secretagogues for burns: A systematic review of effectiveness and safety. Burns : journal of the International Society for Burn Injuries, 2018, Volume: 44, Issue:6 Topics: Burns; Dipeptidyl-Peptidase IV Inhibitors; Disease Management; Exenatide; Glipizide; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Metformin; Pioglitazone; Rosiglitazone; Secretagogues; Sulfonylurea Compounds	2018
Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs. Current cardiology reports, 2009, Volume: 11, Issue:4 Topics: Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Quinolines; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones	2009
Selecting among ADA/EASD tier 1 and tier 2 treatment options. The Journal of family practice, 2009, Volume: 58, Issue:9 Suppl Tr Topics: Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glyburide; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Practice Guidelines as Topic; Prognosis; Risk Assessment; Rosiglitazone; Severity of Illness Index; Thiazolidinediones; Treatment Outcome	2009
Mitochondrial function in skeletal muscle in type 2 diabetes. Danish medical bulletin, 2011, Volume: 58, Issue:4 Topics: Diabetes Mellitus, Type 2; Electron Transport; Humans; Hyperglycemia; Hypoglycemic Agents; Life Style; Mitochondria; Muscle Fibers, Skeletal; Muscle, Skeletal; Obesity; Oxidative Stress; Oxygen Consumption; Rosiglitazone; Saponins; Thiazolidinediones	2011
Rosiglitazone: potential beneficial impact on cardiovascular disease. International journal of clinical practice, 2003, Volume: 57, Issue:2 Topics: Albuminuria; Arteriosclerosis; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Insulin Resistance; Obesity; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones	2003
Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directions. Current opinion in lipidology, 2003, Volume: 14, Issue:6 Topics: Albuminuria; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Carotid Arteries; Coronary Restenosis; Diabetes Mellitus, Type 2; Endothelin-1; Endothelium, Vascular; Humans; Hyperglycemia; Insulin Resistance; Lipoproteins; Matrix Metalloproteinases; Metformin; Muscle, Smooth, Vascular; Pioglitazone; Plasminogen Activator Inhibitor 1; PPAR gamma; Rosiglitazone; Thiazolidinediones	2003
The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled? Current opinion in lipidology, 2007, Volume: 18, Issue:4 Topics: Adult; Aged; Carotid Arteries; Clinical Trials as Topic; Diabetes Mellitus; Disease Progression; Female; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Ramipril; Rosiglitazone; Thiazolidinediones	2007

Trials

10 trial(s) available for rosiglitazone and Hyperglycemia, Postprandial

Article	Year
Effects of rosiglitazone vs metformin on circulating osteoclast and osteogenic precursor cells in postmenopausal women with type 2 diabetes mellitus. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:10 Topics: Aged; Aged, 80 and over; Biomarkers; Bone Remodeling; Cell Lineage; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Middle Aged; Osteoclasts; Postmenopause; Rosiglitazone; Stem Cells; Thiazolidinediones	2014
Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM. Journal of diabetes research, 2015, Volume: 2015 Topics: Adipokines; Adiponectin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hyperglycemia; Hypoglycemic Agents; Inflammation; Insulin; Insulin Secretion; Leptin; Male; Middle Aged; Prognosis; Prospective Studies; Resistin; Rosiglitazone; Thiazolidinediones; Young Adult	2015
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). Journal of the American College of Cardiology, 2009, Jun-02, Volume: 53, Issue:22 Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Carotid Arteries; Carotid Artery Diseases; Fasting; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Ramipril; Rosiglitazone; Single-Blind Method; Thiazolidinediones; Tunica Intima; Ultrasonography	2009
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism: clinical and experimental, 2010, Volume: 59, Issue:2 Topics: Aged; Berberine; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Female; Gene Expression; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liver Diseases; Male; Metformin; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Insulin; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones	2010
Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin. Diabetes care, 2010, Volume: 33, Issue:5 Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Female; Glucose Clamp Technique; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Peptides; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Venoms; Weight Gain	2010
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetic medicine : a journal of the British Diabetic Association, 2010, Volume: 27, Issue:11 Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Ramipril; Risk Assessment; Rosiglitazone; Thiazolidinediones	2010
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:5 Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Postprandial Period; Rosiglitazone; Thiazolidinediones	2004
[DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease]. Revue medicale de Liege, 2006, Volume: 61, Issue:10 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Ramipril; Rosiglitazone; Thiazolidinediones	2006
Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue. Clinical endocrinology, 2007, Volume: 67, Issue:3 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenocorticotropic Hormone; Blood Glucose; Enzyme Activation; Gene Expression Regulation, Enzymologic; Glucose Tolerance Test; Humans; Hydrocortisone; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Middle Aged; Rosiglitazone; Subcutaneous Fat; Thiazolidinediones	2007
[Three studies in type 2 diabetes: DREAM the wash-out results]. Annales d'endocrinologie, 2007, Volume: 68 Suppl 1 Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hyperglycemia; Hypoglycemic Agents; Ramipril; Rosiglitazone; Thiazolidinediones	2007

Other Studies

56 other study(ies) available for rosiglitazone and Hyperglycemia, Postprandial

Article	Year
Benzoxazinones as PPARgamma agonists. part 1: SAR of three aromatic regions. Bioorganic & medicinal chemistry letters, 2003, Jul-21, Volume: 13, Issue:14 Topics: Adaptor Protein Complex 2; Adipocytes; Animals; Area Under Curve; Biological Availability; Gene Expression; Half-Life; Humans; Hyperglycemia; In Vitro Techniques; Indicators and Reagents; Luciferases; Mice; Microsomes, Liver; Oxazines; Rats; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Subcellular Fractions; Transcription Factors	2003
5-aryl thiazolidine-2,4-diones: discovery of PPAR dual alpha/gamma agonists as antidiabetic agents. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Transcription Factors	2003
Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives. Bioorganic & medicinal chemistry letters, 2010, Apr-01, Volume: 20, Issue:7 Topics: Animals; Benzofurans; Crystallography, X-Ray; Diabetes Mellitus; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Models, Molecular; PPAR gamma	2010
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists. Bioorganic & medicinal chemistry, 2017, 02-15, Volume: 25, Issue:4 Topics: Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Design; Hyperglycemia; Male; Models, Molecular; Molecular Structure; PPAR gamma; Quinoxalines; Rats; Rats, Wistar; Streptozocin; Structure-Activity Relationship; Sulfonylurea Receptors	2017
Hyperglycemia Aggravates Blood-Brain Barrier Disruption Following Diffuse Axonal Injury by Increasing the Levels of Inflammatory Mediators through the PPARγ/Caveolin-1/TLR4 Pathway. Inflammation, 2023, Volume: 46, Issue:1 Topics: Animals; Blood-Brain Barrier; Caveolin 1; Diffuse Axonal Injury; Endothelial Cells; Glucose; Humans; Hyperglycemia; Inflammation Mediators; Interleukin-6; Oxygen; PPAR gamma; Rats; Rosiglitazone; Tight Junction Proteins; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2023
Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice. Physiological reports, 2020, Volume: 8, Issue:3 Topics: Animals; Diabetic Nephropathies; Down-Regulation; Hyperglycemia; Hypoglycemic Agents; Kidney; Male; Mice; Neprilysin; Rosiglitazone	2020
Peroxisome proliferator-activated receptor γ agonists attenuate hyperglycaemia-induced hyaluronan secretion in vascular smooth muscle cells by inhibiting PKCβ2. Cell biochemistry and biophysics, 2013, Volume: 67, Issue:2 Topics: Gene Expression Regulation; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hyperglycemia; Muscle, Smooth, Vascular; Pioglitazone; PPAR gamma; Protein Kinase C beta; Protein Kinase Inhibitors; RNA, Messenger; Rosiglitazone; Thiazolidinediones	2013
Oral green tea catechins transiently lower plasma glucose concentrations in female db/db mice. Journal of medicinal food, 2013, Volume: 16, Issue:4 Topics: Adiponectin; Adipose Tissue; Animals; Anti-Inflammatory Agents; Blood Glucose; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Flavonoids; Hyperglycemia; Hypoglycemic Agents; Inflammation; Intercellular Adhesion Molecule-1; Mice; Mice, Knockout; Mice, Obese; Obesity; Phytotherapy; Plant Extracts; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Gain	2013
Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. PloS one, 2013, Volume: 8, Issue:4 Topics: ADAM Proteins; ADAM17 Protein; Albuminuria; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucose Tolerance Test; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Kidney Diseases; Male; Membrane Proteins; Mice; Peptidyl-Dipeptidase A; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-3; Triglycerides	2013
Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats. Neuroscience, 2013, Oct-10, Volume: 250 Topics: Animals; Blood Glucose; Collagen Type IV; Glucose Transporter Type 1; Hemoglobins; Hyperglycemia; Hypoglycemic Agents; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones	2013
Fucosylated chondroitin sulfate from sea cucumber in combination with rosiglitazone improved glucose metabolism in the liver of the insulin-resistant mice. Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:11 Topics: Animals; Blood Glucose; Body Weight; Chondroitin Sulfates; Diet, High-Fat; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation; Glucose Tolerance Test; Glucose-6-Phosphatase; Glycogen; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hexokinase; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyruvate Kinase; Receptor, Insulin; Rosiglitazone; Sea Cucumbers; Signal Transduction; Thiazolidinediones	2013
Hyperglycemia impairs cytotrophoblast function via stress signaling. American journal of obstetrics and gynecology, 2014, Volume: 211, Issue:5 Topics: Antigens, CD; Diabetes, Gestational; Endoglin; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Interleukin-6; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Placenta Growth Factor; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; PPAR gamma; Pregnancy; Pregnancy Proteins; Pyridines; Receptors, Cell Surface; Rosiglitazone; Signal Transduction; Thiazolidinediones; Trophoblasts; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1	2014
Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver. International journal of medical sciences, 2014, Volume: 11, Issue:10 Topics: Animals; Apolipoproteins; Apolipoproteins M; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Lipocalins; Liver; Male; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones	2014
Acute Hepatic Insulin Resistance Contributes to Hyperglycemia in Rats Following Myocardial Infarction. Molecular medicine (Cambridge, Mass.), 2015, Feb-23, Volume: 21 Topics: Animals; Blood Glucose; Gluconeogenesis; Hyperglycemia; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Myocardial Infarction; Rats; Receptor, Insulin; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Necrosis Factor-alpha	2015
Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Scientific reports, 2015, Apr-01, Volume: 5 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Benzamides; Cell Differentiation; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Experimental; Disease Models, Animal; Hyperglycemia; Indoles; Mice; Osteoblasts; Osteogenesis; Phosphorylation; PPAR gamma; Protein Binding; Rosiglitazone; Thiazolidinediones	2015
Hyperglycemia down-regulates cGMP-dependent protein kinase I expression in first trimester cytotrophoblast cells. Molecular and cellular biochemistry, 2015, Volume: 405, Issue:1-2 Topics: Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Down-Regulation; Female; Glucose; Guanylate Cyclase; Humans; Hyperglycemia; Imidazoles; Pregnancy; Pregnancy Trimester, First; Pyridines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Soluble Guanylyl Cyclase; Thiazolidinediones; Trophoblasts	2015
Padina arborescens Ameliorates Hyperglycemia and Dyslipidemia in C57BL/KsJ-db/db Mice, a Model of Type 2 Diabetes Mellitus. Journal of medicinal food, 2015, Volume: 18, Issue:10 Topics: Adiponectin; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Dyslipidemias; Fasting; Glucose Tolerance Test; Glycated Hemoglobin; Glycogen; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Phaeophyceae; Rosiglitazone; Thiazolidinediones	2015
Herbal formulation, DIA-2 and Rosiglitazone ameliorates hyperglycemia and hepatic steatosis in type 2 diabetic rats. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:16 Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diet, High-Fat; Fatty Liver; Hyperglycemia; Hypoglycemic Agents; Liver Diseases; Plant Extracts; Random Allocation; Rats; Rosiglitazone; Thiazolidinediones	2015
Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression. Vascular pharmacology, 2016, Volume: 78 Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cattle; Cell Adhesion; Diabetes Mellitus; Endothelial Cells; Humans; Hyperglycemia; I-kappa B Kinase; Inflammation; Monocytes; PPAR gamma; Rosiglitazone; Telmisartan; Thiazolidinediones; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	2016
Protective Effects of Red Guava on Inflammation and Oxidative Stress in Streptozotocin-Induced Diabetic Mice. Molecules (Basel, Switzerland), 2015, Dec-12, Volume: 20, Issue:12 Topics: Animals; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Experimental; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Interleukin-10; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Oxidative Stress; Plant Extracts; Psidium; Rosiglitazone; Streptozocin; Taiwan; Thiazolidinediones; Tumor Necrosis Factor-alpha	2015
Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells. Hypertension in pregnancy, 2016, Volume: 35, Issue:2 Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cells, Cultured; Cyclooxygenase 2; Enzyme Inhibitors; Female; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Interleukin-6; p38 Mitogen-Activated Protein Kinases; Placenta Growth Factor; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rosiglitazone; Signal Transduction; Thiazolidinediones; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1	2016
Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1. Biochemical and biophysical research communications, 2008, Aug-08, Volume: 372, Issue:4 Topics: Acetylglucosamine; Acylation; Animals; Cell Line; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Protein Processing, Post-Translational; Rosiglitazone; Sp1 Transcription Factor; Thiazolidinediones; Transcription, Genetic; Zinc Fingers	2008
Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats. European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3 Topics: Animals; Behavior, Animal; Blood Glucose; Cognition; Dietary Fats; Disease Models, Animal; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Maze Learning; Memory; Motor Activity; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Time Factors	2008
The effects of rosiglitazione on renal artery endothelium in diabetic rats. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2008, Volume: 116, Issue:9 Topics: Animals; Blood Glucose; Cell Adhesion; Diabetes Mellitus, Experimental; Endothelium, Vascular; Female; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Reference Values; Renal Artery; Rosiglitazone; Thiazolidinediones	2008
Potential hypoglycemic effect of an ethanol extract of Gynostemma pentaphyllum in C57BL/KsJ-db/db mice. Journal of medicinal food, 2008, Volume: 11, Issue:4 Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucokinase; Glucose Tolerance Test; Glucose-6-Phosphatase; Gynostemma; Hyperglycemia; Hypoglycemic Agents; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Liver; Male; Mice; Mice, Inbred C57BL; Pancreas; Phytotherapy; Plant Extracts; Plant Leaves; Rosiglitazone; Thiazolidinediones	2008
Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance. Journal of the Indian Medical Association, 2008, Volume: 106, Issue:11 Topics: Aged; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Middle Aged; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2008
Rosiglitazone: to be or not to be? Diabetologia, 2009, Volume: 52, Issue:7 Topics: Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Practice Guidelines as Topic; Rosiglitazone; Thiazolidinediones	2009
Effects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus. Biochimica et biophysica acta, 2010, Volume: 1802, Issue:2 Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Dietary Carbohydrates; Gerbillinae; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Insulin; Intracellular Space; Lipids; Male; Rosiglitazone; Thiazolidinediones	2010
The novel function of nesfatin-1: anti-hyperglycemia. Biochemical and biophysical research communications, 2010, Jan-01, Volume: 391, Issue:1 Topics: Anilides; Animals; Appetite Depressants; Blood Glucose; Calcium-Binding Proteins; DNA-Binding Proteins; Eating; Hyperglycemia; Hypolipidemic Agents; Insulin; Mice; Mice, Mutant Strains; Nerve Tissue Proteins; Nucleobindins; Peptide Hormones; Pyrazoles; Pyrimidines; Receptors, Leptin; Rosiglitazone; Thiazolidinediones	2010
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation. Metabolism: clinical and experimental, 2010, Volume: 59, Issue:8 Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hyperglycemia; Hypertension; Insulin; Insulin Resistance; Leptin; PPAR gamma; Rats; Rats, Inbred SHR; Rosiglitazone; Telmisartan; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Gain	2010
PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects. European journal of pharmacology, 2011, Jan-15, Volume: 650, Issue:2-3 Topics: 3T3-L1 Cells; Adipocytes; Animals; Cells, Cultured; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Phenylpropionates; PPAR alpha; PPAR delta; PPAR gamma; Rosiglitazone; Thiazolidinediones; Thiophenes; Water-Electrolyte Balance	2011
Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice. Pharmacological research, 2011, Volume: 63, Issue:4 Topics: Aging; Animals; Collagen; Corn Oil; Diet; Female; Fish Oils; Heart; Hyperglycemia; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Inflammation; Insulin Resistance; Mice; Mice, Inbred C57BL; Rosiglitazone; Thiazolidinediones; Ultrasonography	2011
Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:5 Topics: Animals; Antidepressive Agents; Blood Glucose; Depressive Disorder; Diabetes Mellitus, Type 2; Emotions; Glucose Tolerance Test; Hyperglycemia; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Motor Activity; Psychotic Disorders; Rosiglitazone; Swimming; Thiazolidinediones	2012
Rosiglitazone attenuates NF-κB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells. American journal of physiology. Cell physiology, 2012, Jul-15, Volume: 303, Issue:2 Topics: Cells, Cultured; Endothelial Cells; Humans; Hyperglycemia; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rosiglitazone; Thiazolidinediones; Up-Regulation; Vasodilator Agents	2012
MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model. Journal of ethnopharmacology, 2012, Aug-30, Volume: 143, Issue:1 Topics: Animals; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Female; Glucose Tolerance Test; Glucose Transporter Type 4; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Mice, Inbred C57BL; Ophiopogon; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Plant Roots; Polysaccharides; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; Thiazolidinediones; Triglycerides	2012
Modulation of baroreflex function by rosiglitazone in prediabetic hyperglycemic rats. Physiological research, 2012, Volume: 61, Issue:5 Topics: Animals; Baroreflex; Blood Pressure; Hyperglycemia; Hypoglycemic Agents; Prediabetic State; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2012
Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. Journal of neurochemistry, 2013, Volume: 125, Issue:3 Topics: Adenosine Triphosphate; Anilides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cell Line; Disease Models, Animal; Gene Expression Regulation; Glutamates; Humans; Huntingtin Protein; Huntington Disease; Hyperglycemia; Intracellular Signaling Peptides and Proteins; L-Lactate Dehydrogenase; Male; Mice; Mice, Transgenic; Movement Disorders; Nerve Tissue Proteins; Neurons; Neuropeptides; Neuroprotective Agents; Orexins; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; RNA, Messenger; Rosiglitazone; Sirtuins; Thiazolidinediones; Trans-Activators; Transcription Factors; Transfection; Trinucleotide Repeat Expansion	2013
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. The Journal of clinical investigation, 2003, Volume: 111, Issue:5 Topics: Animals; Blood Glucose; Fatty Acids, Nonesterified; Fatty Liver; Hyperglycemia; Insulin Resistance; Leptin; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Receptors, Leptin; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides	2003
Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone. Journal of molecular and cellular cardiology, 2003, Volume: 35, Issue:4 Topics: Arteriosclerosis; C-Reactive Protein; Endothelium, Vascular; Humans; Hyperglycemia; Hypoglycemic Agents; Rosiglitazone; Saphenous Vein; Thiazolidinediones	2003
Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation, 2003, Oct-21, Volume: 108, Issue:16 Topics: Animals; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Female; Homozygote; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Rosiglitazone; Thiazoles; Thiazolidinediones; Tunica Intima	2003
Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie, 2003, Volume: 85, Issue:12 Topics: Adipose Tissue; Diabetes Mellitus, Type 2; Enhancer Elements, Genetic; Gene Expression Regulation, Enzymologic; Gene Frequency; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Humans; Hyperglycemia; Organ Specificity; Phosphoenolpyruvate Carboxykinase (GTP); Polymorphism, Genetic; PPAR gamma; Promoter Regions, Genetic; RNA, Messenger; Rosiglitazone; Thiazolidinediones	2003
Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes. Diabetologia, 2004, Volume: 47, Issue:12 Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Transgenic; PPAR gamma; Rosiglitazone; Thiazolidinediones	2004
Pharmacological profile of a novel, non-TZD PPARgamma agonist. Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:5 Topics: Adipocytes; Animals; Benzoxazines; Blood Glucose; Diabetes Mellitus, Experimental; Female; Gene Expression Regulation; Glycated Hemoglobin; Hepatocytes; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Lipid Metabolism; Male; Mice; Mice, Obese; PPAR gamma; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Triglycerides	2005
[Dermatomyositis, lipodystrophy and insulin resistance]. Medicina clinica, 2006, Apr-08, Volume: 126, Issue:13 Topics: Child; Dermatomyositis; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipodystrophy; Male; Rosiglitazone; Thiazolidinediones	2006
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clinical chemistry, 2007, Volume: 53, Issue:1 Topics: Acute-Phase Proteins; Adult; Age Factors; Aged; Animals; Biomarkers; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperglycemia; Inflammation; Insulin Resistance; Lipocalin-2; Lipocalins; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Middle Aged; Obesity; Oncogene Proteins; Polymerase Chain Reaction; PPAR gamma; Proto-Oncogene Proteins; Rosiglitazone; Sex Factors; Thiazolidinediones	2007
PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance. Pharmacological research, 2007, Volume: 55, Issue:5 Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Pioglitazone; PPAR gamma; Prediabetic State; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Rosiglitazone; Streptozocin; Thiazolidinediones; Vasoconstriction; Vasoconstrictor Agents	2007
Ensuring drug safety: lessons from the thiazolidinediones. Lancet (London, England), 2007, Sep-29, Volume: 370, Issue:9593 Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hyperglycemia; Hypoglycemic Agents; Myocardial Infarction; Rosiglitazone; Thiazolidinediones	2007
Insulin resistance and impaired functional vasodilation in obese Zucker rats. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:4 Topics: Animals; Antioxidants; Arachidonic Acid; Arterioles; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Disease Models, Animal; Electric Stimulation; Fatty Acids, Unsaturated; Hydrazines; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Kidney Cortex; Male; Muscle, Skeletal; NADPH Oxidases; Obesity; Oxidative Stress; Rats; Rats, Zucker; Receptors, Thromboxane; Rosiglitazone; Spin Labels; Superoxides; Thiazolidinediones; Thromboxanes; Time Factors; Triglycerides; Vasoconstriction; Vasodilation	2008
Controversy over the cardiovascular effects of thiazolidinediones. The American journal of medicine, 2008, Volume: 121, Issue:4 Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hyperglycemia; Insulin Resistance; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Assessment; Rosiglitazone; Survival Rate; Thiazolidinediones	2008
Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone. Brain research. Molecular brain research, 2000, Apr-14, Volume: 77, Issue:1 Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Hypothalamus; Insulin; Intracellular Signaling Peptides and Proteins; Leptin; Neuropeptides; Obesity; Orexins; Protein Precursors; Rats; Rats, Zucker; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness; Transcription, Genetic	2000
[New development in diabetes therapy. 35th Annual Meeting of the German Diabetes Society, Munich, May 5-June 3, 2000]. Der Internist, 2000, Volume: 41, Issue:9 Topics: Chromans; Diabetes Mellitus, Type 2; Germany; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	2000
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Diabetes, obesity & metabolism, 2000, Volume: 2, Issue:6 Topics: Aging; Animals; Cataract; Diabetes Mellitus, Type 2; Glucagon; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Pancreas; Proteinuria; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness; Thirst; Time Factors	2000
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Molecular pharmacology, 2001, Volume: 59, Issue:4 Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Liver; Male; Muscle, Skeletal; Nicotinic Acids; Obesity; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors	2001
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. The Journal of clinical investigation, 2001, Volume: 108, Issue:7 Topics: 3T3 Cells; Adipose Tissue; Animals; Benzhydryl Compounds; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Epoxy Compounds; Fatty Acids; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Leptin; Mice; Mice, Knockout; Nicotinic Acids; Obesity; Receptors, Adrenergic, beta-3; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors	2001
Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism. Journal of internal medicine, 2001, Volume: 250, Issue:5 Topics: Adolescent; Adult; Apolipoproteins B; Body Mass Index; Diabetes Complications; Diabetes Mellitus; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mutation; Plasminogen Activator Inhibitor 1; Receptor, Insulin; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides	2001
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models. Diabetes, 2002, Volume: 51, Issue:4 Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Dose-Response Relationship, Drug; Energy Intake; Energy Metabolism; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Mice; Mice, Mutant Strains; Organic Chemicals; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors	2002